Crossmark

Impaired platelet activity and hypercoagulation in healthy term and moderately preterm newborns during the early neonatal period

Crossref DOI link: https://doi.org/10.1038/s41390-018-0184-8

Published Online: 2018-09-18

Published Print: 2019-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koltsova, Ekaterina M.

Balashova, Ekaterina N.

Ignatova, Anastasiya A.

Poletaev, Alexander V.

Polokhov, Dmitry M.

Kuprash, Anna D.

Ionov, Oleg V.

Kirtbaya, Anna R.

Lenyushkina, Anna A.

Timofeeva, Leyla A.

Zubkov, Victor V.

Degtyarev, Dmitry N.

Sukhikh, Gennady T.

Ataullakhanov, Fazoil I.

Panteleev, Mikhail A.

Balandina, Anna N.
License Information

Text and Data Mining valid from 2018-09-18
More Information

Article History

Received: 10 January 2018

Revised: 29 August 2018

Accepted: 4 September 2018

First Online: 18 September 2018

Competing interests

: F.I.A. is former employee and founder of HemaCore LLC, which holds several patents and patent applications that are related to the diagnostic use of spatial clot growth and has developed an assay under the trade name of Thrombodynamics<sup>®</sup>.